Literature DB >> 10663607

Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating.

R L Chen1, C P Reynolds, R C Seeger.   

Abstract

Neutrophils and mononuclear cells (MNC) can mediate antibody-dependent cellular cytotoxicity (ADCC) against cancer cells. To study cytotoxicity and growth inhibition of neuroblastoma cells by neutrophils and MNC with chimeric anti-disialoganglioside (GD2) monoclonal antibody (mAb) ch14.18, we developed digital image microscopy scanning (DIMSCAN) assays that measure fluorescence of target cells in 96-well plates after 6-18 h (cytotoxicity assay) or 7 days (growth assay). Neuroblastoma cell lines (GD2-positive: SMS-KCN, SMS-LHN, LA-N-1; GD2-negative: SK-N-SH) were preloaded with calcein acetoxymethyl ester for the cytotoxicity assay or labeled in situ after 7 days of culture with fluorescein diacetate in the growth assay. Fluorescence, as quantified by DIMSCAN, was correlated with neuroblastoma cell number in both assays (100-2000 cells/well). In the cytotoxicity test, both neutrophils and MNC effectively mediated ADCC of GD2-positive but not GD2-negative neuroblastoma cell lines. Cytotoxicity of both neutrophils and MNC increased with effector to target cell (E:T) ratio (5-50:1) and mAb ch.14.18 dose (0.1-10 microg/ml). ADCC of neutrophils, but not MNC, increased with addition of GM-CSF. Neutrophils, especially with rhGM-CSF, significantly suppressed growth of GD2-positive cell lines at a high E:T ratio (50:1) and mAb dose (10 microg/ml). Without antibody, neutrophils inhibited growth of one cell line (LA-N-1) but stimulated growth of two others (SMS-KCN, SMS-LHN). If neuroblastoma cells did not express GD2 (SK-N-SH), neutrophils stimulated growth whether or not antibody was present. Neutrophil culture supernatants increased growth of SK-N-SH, LA-N-1, and SMS-KCN cells, and MNC culture supernatants increased growth of SK-N-SH. In conclusion, neutrophils can mediate cytotoxicity and growth inhibition with a chimeric anti-GD2 antibody but also can promote tumor cell growth if antibody is not present or if GD2 is not expressed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10663607     DOI: 10.1007/s002620050008

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  10 in total

1.  Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotype.

Authors:  Sanjeeb Shrestha; Jae Myoung Noh; Shin-Yeong Kim; Hwa-Yong Ham; Yeon-Ja Kim; Young-Jin Yun; Min-Ju Kim; Min-Soo Kwon; Dong-Keun Song; Chang-Won Hong
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

2.  TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.

Authors:  Hung C Tran; Zesheng Wan; Michael A Sheard; Jianping Sun; Jeremy R Jackson; Jemily Malvar; Yibing Xu; Larry Wang; Richard Sposto; Eugene S Kim; Shahab Asgharzadeh; Robert C Seeger
Journal:  Clin Cancer Res       Date:  2016-10-10       Impact factor: 12.531

Review 3.  More than the genes, the tumor microenvironment in neuroblastoma.

Authors:  Lucia Borriello; Robert C Seeger; Shahab Asgharzadeh; Yves A DeClerck
Journal:  Cancer Lett       Date:  2015-11-17       Impact factor: 8.679

4.  Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy.

Authors:  Yin Liu; Hong-Wei Wu; Michael A Sheard; Richard Sposto; Srinivas S Somanchi; Laurence J N Cooper; Dean A Lee; Robert C Seeger
Journal:  Clin Cancer Res       Date:  2013-02-01       Impact factor: 12.531

5.  The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment.

Authors:  Ronit Vogt Sionov; Zvi G Fridlender; Zvi Granot
Journal:  Cancer Microenviron       Date:  2014-06-04

6.  Tumor-endothelium cross talk blocks recruitment of neutrophils to endothelial cells: a novel mechanism of endothelial cell anergy.

Authors:  Roman A Blaheta; Maciej Powerski; Lukasz Hudak; Eva Juengel; Dietger Jonas; Andreas von Knethen; Hans Willhelm Doerr; Jindrich Cinatl
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

7.  Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2.

Authors:  Sascha Troschke-Meurer; Nikolai Siebert; Madlen Marx; Maxi Zumpe; Karoline Ehlert; Oliver Mutschlechner; Hans Loibner; Ruth Ladenstein; Holger N Lode
Journal:  Oncoimmunology       Date:  2019-09-08       Impact factor: 8.110

8.  A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma.

Authors:  Xiao-Mao Tian; Bin Xiang; Yi-Hang Yu; Qi Li; Zhao-Xia Zhang; Chenghao Zhanghuang; Li-Ming Jin; Jin-Kui Wang; Tao Mi; Mei-Lin Chen; Feng Liu; Guang-Hui Wei
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

9.  Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1.

Authors:  Yibing Xu; Jianping Sun; Michael A Sheard; Hung C Tran; Zesheng Wan; Wei Yao Liu; Shahab Asgharzadeh; Richard Sposto; Hong Wei Wu; Robert C Seeger
Journal:  Cancer Immunol Immunother       Date:  2013-08-27       Impact factor: 6.968

10.  Reduction of CD11b+ myeloid suppressive cells augments anti-neuroblastoma immune response induced by the anti-GD2 antibody ch14.18/CHO.

Authors:  Nikolai Siebert; Maxi Zumpe; Leon von Lojewski; Sascha Troschke-Meurer; Madlen Marx; Holger N Lode
Journal:  Oncoimmunology       Date:  2020-10-24       Impact factor: 8.110

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.